반응식
C(N1CCN(C2C=[C:11]([NH:15][C:16]([C:18]3[C:19]4[N:20]=[CH:21][CH:22]=[N:23][C:24]=4[C:25]([C:28]4[C:37]5[C:32](=[CH:33][CH:34]=[CH:35][CH:36]=5)[CH:31]=[N:30][CH:29]=4)=[CH:26][CH:27]=3)=[O:17])C=CC=2)CC1)C>C(Cl)Cl.CO>[NH:20]1[CH:19]=[CH:24][N:23]=[C:11]1[NH:15][C:16]([C:18]1[C:19]2[N:20]=[CH:21][CH:22]=[N:23][C:24]=2[C:25]([C:28]2[C:37]3[C:32](=[CH:33][CH:34]=[CH:35][CH:36]=3)[CH:31]=[N:30][CH:29]=2)=[CH:26][CH:27]=1)=[O:17]참가 물질
3
실험 절차
The title compound was prepared in analogy to the procedures described in Example 14 but using 8-isoquinolin-4-yl-quinoxaline-5-carboxylic acid (Example 52) in Step 14.1. Title compound: ESI-MS: 367.0 [M+H]+; TLC: Rf=0.17 (DCM/MeOH, 95:5).
후처리
- customThe title compound was prepared in analogy to the procedures
출처 및 근거
- ORD 기록
- ord-8eae1e4ed1c14776b9ad04f92266012b
- 출처 데이터셋
- uspto-grants-2012_09
- 특허 번호
- US08273882B2
연결된 노트
불러오는 중…